Nearly one in four do not recover from COVID-19 by 90 days
Jun 19, 2024
Female sex and preexisting cardiovascular disease were tied to longer recovery times.
Midlife inflammation tied to slowing of gait speed in later life
Jun 14, 2024
The findings occurred even among otherwise healthy adults and regardless of race or socioeconomic disadvantage.
Healthcare spending growth projected to outpace GDP to 2032
Jun 13, 2024
National health expenditures are projected to have increased 7.5% in 2023, when the COVID-19 public health emergency ended.
Residual risk seen for death, postacute sequelae in third year after COVID-19 hospitalization
Jun 13, 2024
The risk for death remains significantly elevated in the third year, as is risk for incident postacute sequelae of COVID-19.
‘Private equity abuse’ in long-term care is target of new federal bill
By
Lois A. Bowers
Jun 13, 2024
Two Democratic senators from Massachusetts have introduced a bill they say is meant to “root out corporate greed and private equity abuse” in nursing homes, assisted living communities, home health...
Almost a third of retirees consider picking up temporary jobs
By
Kathleen Steele Gaivin
Jun 12, 2024
One third of retirees are considering picking up one to three shifts of temporary work per week because their cost of living is increasing, according to Indeed Flex, an online temporary staffing platform.
Expert panel develops new definition of long COVID
Jun 11, 2024
A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.
Travel can benefit both family caregivers and care recipients: AARP
By
Kathleen Steele Gaivin
Jun 11, 2024
Despite challenges, there are innate benefits for family caregivers when they do make trips with their care recipients, according to the results of a survey by the AARP.
Vitamin D suggested for children, seniors, those with high-risk prediabetes
Jun 10, 2024
No evidence was seen to support routine 25(OH)D screening in the general population.
Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.